http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 29 Jun 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Press+Releases/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Globe+Newswire/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Globe+Newswire/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Globe+Newswire/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Globe+Newswire/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN http://www.streetinsider.com/Globe+Newswire/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html <p align="justify">ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced the appointment of Srishti Gupta, MD MPP as Chief Executive Officer and a member of the Company&apos;s Board of Directors, effective July 1, 2026. Xi-Yong (Sean) Fu, PhD MBA will step down as Chief Executive Officer to pursue other opportunities. Dr. Fu will support the Company in an advisory capacity during the transition.</p> <p align="justify">Dr. Gupta is an experienced CEO who brings more than two http://www.streetinsider.com/Globe+Newswire/NovaBridge+Biosciences+Appoints+Dr.+Srishti+Gupta+as+Chief+Executive+Officer/26701859.html Mon, 29 Jun 2026 07:00:00 -0400 A.02417891 A.07880129 A.17990879 A.35954321 A.50216867 A.60012009 A.60012009 IDIA IVVD NBP O.01104310 O.10045310 O.20042353 O.20737027 O.21025396 O.21200813 O.31391011 O.34387572 O.38348529 O.41779920 O.48073352 SANN